Today: 19 April 2026
Browse Category

NSE:COFORGE 9 December 2025 - 29 December 2025

PNB fraud alert, Coforge’s $2.35 billion Encora deal and MCX split: India stocks to watch Monday

PNB fraud alert, Coforge’s $2.35 billion Encora deal and MCX split: India stocks to watch Monday

Punjab National Bank reported a 24.34 billion rupee loan fraud involving former promoters of two SREI Group firms. Coforge announced a $2.35 billion deal to acquire AI firm Encora, with combined annual revenue projected at $2.5 billion. A-1 Ltd will trade ex-bonus Dec. 31, issuing three bonus shares per share held, and shifted its stock split record date to Jan. 8, 2026.
29 December 2025
Coforge’s $2.35 billion Encora deal tops India’s stocks-to-watch list for Dec. 29

Coforge’s $2.35 billion Encora deal tops India’s stocks-to-watch list for Dec. 29

Coforge agreed to acquire U.S.-based Encora for $2.35 billion and will raise up to $550 million via a share sale to fund the deal. Punjab National Bank reported a 24.34 billion-rupee fraud to regulators. Timex Group India’s promoter plans to sell up to 8.93% on Dec. 29–30. GIFT Nifty futures rose 40 points to 26,100 ahead of Monday’s open.
Biggest Stock Losers Today in India (9 December 2025): Asian Paints, LT Foods, ITC Hotels, Coforge Drag Nifty & Sensex

Biggest Stock Losers Today in India (9 December 2025): Asian Paints, LT Foods, ITC Hotels, Coforge Drag Nifty & Sensex

Indian stocks fell sharply by late morning Tuesday, with the Sensex down 468 points near 84,634 and Nifty 50 lower by 0.55% around 25,819. Mid- and small-cap indices dropped about 1.5% each. Asian Paints slid nearly 4%, leading large-cap declines, while Infosys, M&M, Wipro, and Tata Steel also fell. Over 380 NSE stocks hit 52-week lows as market breadth remained weak.

Stock Market Today

  • 2 TSX Stocks Under $100 with Strong Upside Potential
    April 18, 2026, 9:56 PM EDT. CES Energy (TSX:CEU) and Bird Construction are two TSX-listed stocks priced below $100 that offer significant growth potential. CES Energy provides consumable chemical solutions to oil and gas producers, benefiting from rising service intensity and demand for advanced chemical treatments. Despite softer drilling activity, CES's revenue growth remains robust, supported by its asset-light model and strategic acquisitions. Macro trends like growing global energy demand and LNG infrastructure expansion further boost its outlook. Bird Construction, also trading under $100, stands out for its presence in the construction sector, which benefits from infrastructure spending and urban development. Both companies show disciplined capital allocation and resilient revenue drivers, making them attractive for investors seeking accessible entry points and potential capital appreciation on the TSX.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Go toTop